To assess the effect of clinical and pathological variables on cancer-specific and overall survival (OS) in de novo metastatic patients from a collaborative of primarily Latin American countries.
Of 4,060 patients with renal cell carcinoma diagnosed between 1990 and 2015, a total of 530 (14.